These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6186747)

  • 1. Hla, and the response to treatment with gamma-type endorphins in schizophrenia.
    de Jongh BM; Verhoeven WM; van Ree JM; de Wied D; van Rood JJ
    J Immunogenet; 1982 Dec; 9(6):381-8. PubMed ID: 6186747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endorphins of the gamma type in the treatment of schizophrenic psychoses].
    Verhoeven WM; Van Ree JM
    Acta Psychiatr Belg; 1984; 84(2):160-72. PubMed ID: 6204507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of schizophrenic psychoses with gamma-type endorphins.
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Biol Psychiatry; 1982 Jan; 17(1):83-98. PubMed ID: 6174158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction between gamma-type endorphins and HLA class I antigens.
    Claas FH; van Ree JM; Verhoeven WM; van der Poel JJ; Verduyn W; de Wied D; van Rood JJ
    Hum Immunol; 1986 Apr; 15(4):347-56. PubMed ID: 2422143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic-like and antipsychotic effects of gamma-type endorphins.
    Van Ree JM; Verhoeven WM; Van Praag HM; De Wied D
    Mod Probl Pharmacopsychiatry; 1981; 17():266-78. PubMed ID: 6173744
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of schizophrenic psychoses with gamma-type endorphins].
    van Praag HM; Verhoeven WM; van Ree JM; de Wied D
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1963-9. PubMed ID: 6171738
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of the synthetic peptides gamma-type endorphins in mentally ill patients.
    van Ree JM; Verhoeven WM; de Wied D; van Praag HM
    Ann N Y Acad Sci; 1982; 398():478-95. PubMed ID: 6186176
    [No Abstract]   [Full Text] [Related]  

  • 8. HLA as regulator.
    van Rood JJ
    Ann Rheum Dis; 1984 Oct; 43(5):665-72. PubMed ID: 6208855
    [No Abstract]   [Full Text] [Related]  

  • 9. Gamma-type endorphins: neurolepticum-like and antipsychotic action.
    Van Ree JM; Verhoeven WM; De Wied D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):561-7. PubMed ID: 2418467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic efficacy of neuroleptic neuropeptides in schizophrenia. Review of clinical data].
    Verhoeven VM
    Encephale; 1987; 13(6):349-56. PubMed ID: 2453339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients.
    Verhoeven WM; van Ree JM; Heezius-van Bentum A; de Wied D; van Praag HM
    Arch Gen Psychiatry; 1982 Jun; 39(6):648-54. PubMed ID: 7092498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on the antipsychotic properties of desenkephalin-gamma-endorphin and ceruletide in schizophrenic patients.
    Verhoeven WM; Westenberg HG; van Ree JM
    Acta Psychiatr Scand; 1986 Apr; 73(4):372-82. PubMed ID: 3524119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.
    Verhoeven WM; van Ree JM; Westenberg HG; Krul JM; Brouwer GJ; Thijssen JH; de Wied D; van Praag HM; Ceulemans DL; Kahn RS
    Psychiatry Res; 1984 Apr; 11(4):329-46. PubMed ID: 6204351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endorphin research in schizophrenic psychoses.
    Van Praag HM; Verhoeven WM
    Compr Psychiatry; 1981; 22(2):135-46. PubMed ID: 6260424
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of [Des-Tyr1]-gamma-endorphin in schizophrenia.
    Emrich HM; Zaudig M; v Zerssen D; Kissling W; Dirlich G; Herz A
    Mod Probl Pharmacopsychiatry; 1981; 17():279-86. PubMed ID: 7329421
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of (Des-Tyr)-gamma-endorphin in schizophrenia.
    Meltzer HY; Busch DA; Tricou BJ; Robertson A
    Psychiatry Res; 1982 Jun; 6(3):313-26. PubMed ID: 6125982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA antigens in patients with and without a family history of schizophrenia.
    Rudduck C; Franzén G; Löw B; Rorsman B
    Hum Hered; 1984; 34(5):291-6. PubMed ID: 6592138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Des-tyrosine-gamma-endorphin administration in chronic schizophrenics. A preliminary report.
    Tamminga CA; Tighe PJ; Chase TN; DeFraites EG; Schaffer MH
    Arch Gen Psychiatry; 1981 Feb; 38(2):167-8. PubMed ID: 7212942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endorphins and schizophrenias. II. Trial treatment of schizophrenia with des-Tyr-gamma-endorphin (DT gamma E) (including a personal trial)].
    Bourgeois M; Laforge E; Muyard J; Blayac J; Lemoine J
    Ann Med Psychol (Paris); 1980 Nov; 138(9):1112-9. PubMed ID: 6111283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.